The U.S. Defense Logistics Agency (DLA) awarded a $29,106.50 firm fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FRV73) to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of October 7, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to provide a wide range of essential medical commodities, including prescription drugs, specialty medications, and medical supplies, in support of federal healthcare programs and military treatment facilities. This contract award does not utilize any set-aside designation.
Generated 12/16/24, 2:37 PM